A Pathway and Approach to Biomarker Validation and Qualification for Osteoarthritis Clinical Trials

Author(s): David J. Hunter, Elena Losina, Ali Guermazi, Deb Burstein, Marissa N. Lassere, Virginia Kraus

Journal Name: Current Drug Targets

Volume 11 , Issue 5 , 2010

Become EABM
Become Reviewer
Call for Editor


This narrative review outlines the work done in other fields with regards biomarker validation and qualification and the lessons that we may learn from this experience. Defining a universally agreed upon path for biomarker validation and qualification is urgently needed to circumvent many of the hurdles faced in OA therapeutic development irrespective of whether we are discussing biochemical markers, imaging markers or other measures. This review proposes a path that may be suitable for osteoarthritis and poses some logical next steps that will take us in this direction.

Keywords: Osteoarthritis, biomarkers, imaging, biochemical marker, validation, qualification, intervention, surrogate

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2010
Page: [536 - 545]
Pages: 10
DOI: 10.2174/138945010791011947
Price: $65

Article Metrics

PDF: 18